 | • レポートコード：MRC2-11QY04226 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腹膜がんのグローバル市場について調査・分析したレポートです。種類別（手術、化学療法（抗がん剤）、放射線療法（高エネルギー光線））市場規模、用途別（がん研究センター、がん病院、外科センター、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腹膜がんの競争状況、市場シェア ・世界の腹膜がん市場：種類別市場規模 2015年-2020年（手術、化学療法（抗がん剤）、放射線療法（高エネルギー光線）） ・世界の腹膜がん市場：種類別市場規模予測 2021年-2026年（手術、化学療法（抗がん剤）、放射線療法（高エネルギー光線）） ・世界の腹膜がん市場：用途別市場規模 2015年-2020年（がん研究センター、がん病院、外科センター、クリニック） ・世界の腹膜がん市場：用途別市場規模予測 2021年-2026年（がん研究センター、がん病院、外科センター、クリニック） ・北米の腹膜がん市場分析：米国、カナダ ・ヨーロッパの腹膜がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腹膜がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腹膜がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腹膜がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、GlaxoSmithKline、Oxford BioMedica、Millennium Pharmaceuticals、Novartis、Bayer、Incyte、EntreMed、Oncolytics Biotech、Synta Pharmaceuticals、Oasmia Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Peritoneal cancer is also known as serous surface papillary carcinoma, primary peritoneal carcinoma, extra-ovarian serous carcinoma, primary serous papillary carcinoma and psammomacarcinoma.
Peritoneal cancer develops in a thin layer of tissue that lines the abdomen. It also covers the uterus, bladder and rectum.
Market Analysis and Insights: Global Peritoneal Cancer Market
The global Peritoneal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Peritoneal Cancer Scope and Market Size
Peritoneal Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peritoneal Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AstraZeneca
GlaxoSmithKline
Oxford BioMedica
Millennium Pharmaceuticals
Novartis
Bayer
Incyte
EntreMed
Oncolytics Biotech
Synta Pharmaceuticals
Oasmia Pharmaceutical
Market segment by Type, the product can be split into
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
Market segment by Application, split into
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Peritoneal Cancer Revenue
1.4 Market by Type
1.4.1 Global Peritoneal Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Chemotherapy (Anticancer Drugs)
1.4.4 Radiotherapy (High-Energy Rays)
1.5 Market by Application
1.5.1 Global Peritoneal Cancer Market Share by Application: 2020 VS 2026
1.5.2 Cancer Research Centers
1.5.3 Cancer Hospital
1.5.4 Surgical Centers
1.5.5 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Peritoneal Cancer Market Perspective (2015-2026)
2.2 Global Peritoneal Cancer Growth Trends by Regions
2.2.1 Peritoneal Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Peritoneal Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Peritoneal Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Peritoneal Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key Peritoneal Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Peritoneal Cancer Players by Market Size
3.1.1 Global Top Peritoneal Cancer Players by Revenue (2015-2020)
3.1.2 Global Peritoneal Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global Peritoneal Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Peritoneal Cancer Market Concentration Ratio
3.2.1 Global Peritoneal Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Peritoneal Cancer Revenue in 2019
3.3 Peritoneal Cancer Key Players Head office and Area Served
3.4 Key Players Peritoneal Cancer Product Solution and Service
3.5 Date of Enter into Peritoneal Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peritoneal Cancer Historic Market Size by Type (2015-2020)
4.2 Global Peritoneal Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Peritoneal Cancer Market Size by Application (2015-2020)
5.2 Global Peritoneal Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Peritoneal Cancer Market Size (2015-2020)
6.2 Peritoneal Cancer Key Players in North America (2019-2020)
6.3 North America Peritoneal Cancer Market Size by Type (2015-2020)
6.4 North America Peritoneal Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe Peritoneal Cancer Market Size (2015-2020)
7.2 Peritoneal Cancer Key Players in Europe (2019-2020)
7.3 Europe Peritoneal Cancer Market Size by Type (2015-2020)
7.4 Europe Peritoneal Cancer Market Size by Application (2015-2020)
8 China
8.1 China Peritoneal Cancer Market Size (2015-2020)
8.2 Peritoneal Cancer Key Players in China (2019-2020)
8.3 China Peritoneal Cancer Market Size by Type (2015-2020)
8.4 China Peritoneal Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan Peritoneal Cancer Market Size (2015-2020)
9.2 Peritoneal Cancer Key Players in Japan (2019-2020)
9.3 Japan Peritoneal Cancer Market Size by Type (2015-2020)
9.4 Japan Peritoneal Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Peritoneal Cancer Market Size (2015-2020)
10.2 Peritoneal Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Peritoneal Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia Peritoneal Cancer Market Size by Application (2015-2020)
11 India
11.1 India Peritoneal Cancer Market Size (2015-2020)
11.2 Peritoneal Cancer Key Players in India (2019-2020)
11.3 India Peritoneal Cancer Market Size by Type (2015-2020)
11.4 India Peritoneal Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Peritoneal Cancer Market Size (2015-2020)
12.2 Peritoneal Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America Peritoneal Cancer Market Size by Type (2015-2020)
12.4 Central & South America Peritoneal Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AstraZeneca
13.1.1 AstraZeneca Company Details
13.1.2 AstraZeneca Business Overview
13.1.3 AstraZeneca Peritoneal Cancer Introduction
13.1.4 AstraZeneca Revenue in Peritoneal Cancer Business (2015-2020))
13.1.5 AstraZeneca Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Peritoneal Cancer Introduction
13.2.4 GlaxoSmithKline Revenue in Peritoneal Cancer Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Oxford BioMedica
13.3.1 Oxford BioMedica Company Details
13.3.2 Oxford BioMedica Business Overview
13.3.3 Oxford BioMedica Peritoneal Cancer Introduction
13.3.4 Oxford BioMedica Revenue in Peritoneal Cancer Business (2015-2020)
13.3.5 Oxford BioMedica Recent Development
13.4 Millennium Pharmaceuticals
13.4.1 Millennium Pharmaceuticals Company Details
13.4.2 Millennium Pharmaceuticals Business Overview
13.4.3 Millennium Pharmaceuticals Peritoneal Cancer Introduction
13.4.4 Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2015-2020)
13.4.5 Millennium Pharmaceuticals Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Peritoneal Cancer Introduction
13.5.4 Novartis Revenue in Peritoneal Cancer Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Peritoneal Cancer Introduction
13.6.4 Bayer Revenue in Peritoneal Cancer Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Incyte
13.7.1 Incyte Company Details
13.7.2 Incyte Business Overview
13.7.3 Incyte Peritoneal Cancer Introduction
13.7.4 Incyte Revenue in Peritoneal Cancer Business (2015-2020)
13.7.5 Incyte Recent Development
13.8 EntreMed
13.8.1 EntreMed Company Details
13.8.2 EntreMed Business Overview
13.8.3 EntreMed Peritoneal Cancer Introduction
13.8.4 EntreMed Revenue in Peritoneal Cancer Business (2015-2020)
13.8.5 EntreMed Recent Development
13.9 Oncolytics Biotech
13.9.1 Oncolytics Biotech Company Details
13.9.2 Oncolytics Biotech Business Overview
13.9.3 Oncolytics Biotech Peritoneal Cancer Introduction
13.9.4 Oncolytics Biotech Revenue in Peritoneal Cancer Business (2015-2020)
13.9.5 Oncolytics Biotech Recent Development
13.10 Synta Pharmaceuticals
13.10.1 Synta Pharmaceuticals Company Details
13.10.2 Synta Pharmaceuticals Business Overview
13.10.3 Synta Pharmaceuticals Peritoneal Cancer Introduction
13.10.4 Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2015-2020)
13.10.5 Synta Pharmaceuticals Recent Development
13.11 Oasmia Pharmaceutical
10.11.1 Oasmia Pharmaceutical Company Details
10.11.2 Oasmia Pharmaceutical Business Overview
10.11.3 Oasmia Pharmaceutical Peritoneal Cancer Introduction
10.11.4 Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2015-2020)
10.11.5 Oasmia Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Peritoneal Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by Peritoneal Cancer Revenue
Table 3. Ranking of Global Top Peritoneal Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Peritoneal Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Chemotherapy (Anticancer Drugs)
Table 7. Key Players of Radiotherapy (High-Energy Rays)
Table 8. Global Peritoneal Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Peritoneal Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Peritoneal Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Peritoneal Cancer Market Share by Regions (2015-2020)
Table 12. Global Peritoneal Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Peritoneal Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Peritoneal Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key Peritoneal Cancer Players
Table 19. Global Peritoneal Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global Peritoneal Cancer Market Share by Players (2015-2020)
Table 21. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peritoneal Cancer as of 2019)
Table 22. Global Peritoneal Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Peritoneal Cancer Product Solution and Service
Table 25. Date of Enter into Peritoneal Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global Peritoneal Cancer Market Size Share by Type (2015-2020)
Table 29. Global Peritoneal Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global Peritoneal Cancer Market Size Share by Application (2015-2020)
Table 31. Global Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global Peritoneal Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Peritoneal Cancer Market Share (2019-2020)
Table 35. North America Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America Peritoneal Cancer Market Share by Type (2015-2020)
Table 37. North America Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America Peritoneal Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Peritoneal Cancer Market Share (2019-2020)
Table 41. Europe Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Peritoneal Cancer Market Share by Type (2015-2020)
Table 43. Europe Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Peritoneal Cancer Market Share by Application (2015-2020)
Table 45. China Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players Peritoneal Cancer Market Share (2019-2020)
Table 47. China Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China Peritoneal Cancer Market Share by Type (2015-2020)
Table 49. China Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China Peritoneal Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Peritoneal Cancer Market Share (2019-2020)
Table 53. Japan Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Peritoneal Cancer Market Share by Type (2015-2020)
Table 55. Japan Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Peritoneal Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Peritoneal Cancer Market Share (2019-2020)
Table 59. Southeast Asia Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Peritoneal Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Peritoneal Cancer Market Share by Application (2015-2020)
Table 63. India Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players Peritoneal Cancer Market Share (2019-2020)
Table 65. India Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India Peritoneal Cancer Market Share by Type (2015-2020)
Table 67. India Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India Peritoneal Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Peritoneal Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Peritoneal Cancer Market Share (2019-2020)
Table 71. Central & South America Peritoneal Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Peritoneal Cancer Market Share by Type (2015-2020)
Table 73. Central & South America Peritoneal Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Peritoneal Cancer Market Share by Application (2015-2020)
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Product
Table 78. AstraZeneca Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 79. AstraZeneca Recent Development
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline Recent Development
Table 85. Oxford BioMedica Company Details
Table 86. Oxford BioMedica Business Overview
Table 87. Oxford BioMedica Product
Table 88. Oxford BioMedica Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 89. Oxford BioMedica Recent Development
Table 90. Millennium Pharmaceuticals Company Details
Table 91. Millennium Pharmaceuticals Business Overview
Table 92. Millennium Pharmaceuticals Product
Table 93. Millennium Pharmaceuticals Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 94. Millennium Pharmaceuticals Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Product
Table 103. Bayer Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 104. Bayer Recent Development
Table 105. Incyte Company Details
Table 106. Incyte Business Overview
Table 107. Incyte Product
Table 108. Incyte Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 109. Incyte Recent Development
Table 110. EntreMed Business Overview
Table 111. EntreMed Product
Table 112. EntreMed Company Details
Table 113. EntreMed Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 114. EntreMed Recent Development
Table 115. Oncolytics Biotech Company Details
Table 116. Oncolytics Biotech Business Overview
Table 117. Oncolytics Biotech Product
Table 118. Oncolytics Biotech Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 119. Oncolytics Biotech Recent Development
Table 120. Synta Pharmaceuticals Company Details
Table 121. Synta Pharmaceuticals Business Overview
Table 122. Synta Pharmaceuticals Product
Table 123. Synta Pharmaceuticals Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 124. Synta Pharmaceuticals Recent Development
Table 125. Oasmia Pharmaceutical Company Details
Table 126. Oasmia Pharmaceutical Business Overview
Table 127. Oasmia Pharmaceutical Product
Table 128. Oasmia Pharmaceutical Revenue in Peritoneal Cancer Business (2015-2020) (Million US$)
Table 129. Oasmia Pharmaceutical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peritoneal Cancer Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Chemotherapy (Anticancer Drugs) Features
Figure 4. Radiotherapy (High-Energy Rays) Features
Figure 5. Global Peritoneal Cancer Market Share by Application: 2020 VS 2026
Figure 6. Cancer Research Centers Case Studies
Figure 7. Cancer Hospital Case Studies
Figure 8. Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Peritoneal Cancer Report Years Considered
Figure 11. Global Peritoneal Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Peritoneal Cancer Market Share by Regions: 2020 VS 2026
Figure 13. Global Peritoneal Cancer Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Peritoneal Cancer Market Share by Players in 2019
Figure 16. Global Top Peritoneal Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peritoneal Cancer as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Peritoneal Cancer Revenue in 2019
Figure 18. North America Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Peritoneal Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
肺癌の世界市場（～2026年） Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as prim…- 甲状腺がん治療の世界市場（～2026年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Thyroid Cancer Treatment Scope and Market Size Thyroid Cancer Tre…
- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- 上咽頭がんの世界市場（～2026年） Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus. Increasing geriatric population, rise in con…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …